FDA Expands Opdivo Approval
The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy.
Melanoma Rx May Treat Lung Cancer, Too
Turns out a melanoma medication could also help patients with a different type of cancer.
Advanced Non-Small Cell Lung Cancer Rx Approved
The U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda is approved for use with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, the first test designed to detect PD-L1 expression in non-small cell lung tumors.
New Guidelines for Smokers' Health Care
Smoking has been tied to numerous health issues. Now an expert panel has made recommendations for doctors who care for adults and pregnant women who smoke.
How Ethnicity Affects Cancer Risk
Your ethnicity may be a factor in your cancer risk.
How to Quit Smoking
You’ve decided to kick the habit? That’s great! Read on to learn your options and prepare yourself before you pitch your last pack — it could make all the difference in your success!
FDA Approves Targeted Rx for Lung Cancer
The U.S. Food and Drug Administration today approved Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors harbor specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.
Living up to Your Potential Life Span
No one lives forever. But you may be able to increase your life span.
Smoking Might Be Even More Dangerous Than You Think
There are countless reasons to quit smoking. And new data may add 12 more reasons to the list.
Lung Cancer Rx Might Outperform Chemo
When you're sick, you may feel like the immune system is a weak tool for protecting the body. But new evidence is showing how medications might activate the immune system to treat a very serious illness — lung cancer.